Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.42M Buy
182,418
+143,544
+369% +$2.88M 0.08% 382
2026
Q2
$721K Sell
38,874
-85,025
-69% -$1.69M 0.01% 1181
2026
Q1
$2.33M Buy
+123,899
New +$2.33M 0.04% 649
2025
Q2
– Sell
-46,271
Closed -$704K – 1893
2025
Q1
$704K Sell
46,271
-31,917
-41% -$478K 0.05% 550
2024
Q4
$1.14M Sell
78,188
-29,049
-27% -$454K 0.08% 374
2024
Q3
$1.71M Buy
+107,237
New +$1.9M 0.1% 253
2024
Q1
– Sell
-11,003
Closed -$223K – 1634
2023
Q4
$223K Buy
+11,003
New +$216K 0.02% 954
2021
Q4
– Sell
-27,298
Closed -$358K – 785
2021
Q3
$358K Buy
+27,298
New +$368K 0.07% 423

Other funds holding NOV

Y-Intercept (HK)'s NOV Position: Q3 2026 in Review

Y-Intercept (HK) increased its NOV (NOV) stake by 369% in Q3 2026, buying an estimated $2.88M and bringing the position to 182,418 shares worth $3.42M. The position accounts for 0.08% of the portfolio, ranked #382.

Y-Intercept (HK) first reported a position in NOV in Q3 2021 and has held it in 8 quarters since. 81 funds tracked by Wall St. Rank hold NOV as of Q3 2026.

  • Y-Intercept (HK) held 182,418 shares of NOV worth $3.42M as of Q3 2026.
  • Y-Intercept (HK) bought 143,544 NOV shares in Q3 2026, an estimated $2.88M.
  • NOV made up 0.08% of Y-Intercept (HK)'s portfolio in Q3 2026, its #382 holding.
  • Y-Intercept (HK) first reported a position in NOV in Q3 2021 and has held it in 8 quarters since.
  • 81 funds tracked by Wall St. Rank held NOV as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.